This page describes pharmacological agents that may have legal restrictions, side effects, and drug interactions in your jurisdiction. Information is for educational research only — consult a clinician before considering any compound.
Panax Ginseng
The "true" ginseng of Chinese and Korean traditional medicine — Panax ginseng C.A.
Aliases (7)
Overview
What is Panax Ginseng?
Panax ginseng (Asian/Korean ginseng) is the root of Panax ginseng C.A. Meyer, a traditional Chinese and Korean medicinal herb classified as an adaptogen. The active constituents are triterpenoid saponins called ginsenosides (Rb1, Rg1, Re, Rc, Rd, etc.).
Key Benefits
Reported to reduce fatigue, improve cognitive performance (working memory, reaction time), enhance physical endurance, and modulate stress response. Some evidence supports use in erectile dysfunction, immune function, and as adjunct in type 2 diabetes glycemic control.
Mechanism of Action
Ginsenosides modulate the HPA axis (reducing cortisol reactivity), enhance nitric oxide production, and modulate neurotransmitter systems including dopamine, serotonin, and GABA. Some ginsenosides act as partial estrogen receptor and steroid hormone receptor modulators.
Research Indications
Protopanaxadiols (PPD) — Rb1, Rb2, Rc, Rd, Rg3, Rh2, compound K
CNS-modulating, anti-inflammatory, insulin-sensitizing
Protopanaxatriols (PPT) — Rg1, Re, Rf, Rh1
stimulating-leaning, pro-cognitive, NO-mediated vasodilation
Oleanane (Ro)
anti-inflammatory minor
Research Protocols
Disclaimer: These are commonly discussed research protocols and not medical advice.
Peptide Interactions
Reay's later work on ginseng + caffeine demonstrated additive cognitive endurance benefits. Once Dylan establishes his caffeine baseline (currently ramping i…
Smooths the mild stim signal, reduces any nascent jitter, no cognitive blunting. 200 mg co-administered is the standard pairing.
Compound cholinergic support. Ginsenoside Rb1 raises CNS acetylcholine release; citicoline raises choline substrate availability. Mechanistically complementa…
Both adaptogens but with distinct mechanisms (rhodiola = monoamine + cortisol-buffering, Panax = NMDA + cholinergic + glucose). Some users layer; cleaner app…
Mechanistically distinct (modafinil = orexin/histamine/DAT, Panax = NMDA/ACh/Rg3 D2). Plausible additive cognitive benefit; no known interaction. Watch BP an…
Traditional pairing in Chinese herbal compounds; some cognitive trial data on the combination (Wesnes 2000). Mild bleed-risk additive at high doses if also o…
Different stress / HPA endpoint emphasis (ashwagandha is more anxiolytic-night, Panax more mild-stim-AM). Plausibly complementary at different times of day.
Some practitioners alternate or combine the two species to balance "warming/yang" (P. ginseng) and "cooling/yin" (P. quinquefolius) framings. No formal combo…
Case reports of mania, headache, hypertensive responses. Hard avoid.
Documented case-report INR reduction (multiple) with some opposing reports of potentiation. Do not combine without prescriber-monitored INR.
Additive hypoglycemia risk. Combine only with prescriber awareness and frequent fingerstick monitoring early on.
(amphetamines, methylphenidate at higher dose) — Cumulative stim/cardiovascular load with minimal additional cognitive benefit; possibly worsens anxiety prof…
What to Expect
- Acutesingle-dose effects: 30–90 minutes after ingestion of a standardized extract (G115, Cereboost, KGC). Peak 1.5–3 hours.
- Chronic/ adaptogenic effects: Build over 1–4 weeks of daily dosing. Some users report nothing for the first 5–10 days then a gradual lift in baseline energy and fat…
Side Effects & Safety 8
Side Effects
- 1Mild GI upset — bloating, loose stools, nausea — concentrated in week 1. More common on raw-root powder than standardized extract.
- 2Mild headache in first 1–3 doses; usually resolves.
- 3Insomnia / shifted sleep onset if dosed afternoon/PM.
- 4Variable BP — usually small drops (~3–5 mmHg); occasional rises at higher doses.
- 5Irritability / restlessness at >300–400 mg/day high-quality extract.
- 6Vivid dreams (uncommon, more on KRG).
- 7Menstrual cycle perturbations — possibly weak estrogenic activity.
- 8Mild hypoglycemic symptoms in fasted users or those on glucose-lowering meds.
When to Stop
- "Ginseng abuse syndrome" (Siegel 1979 — chronic >3 g/day): insomnia, HTN, irritability, morning diarrhea, skin eruptions. Original case series confounded with other stimulants. Not a concern at clinical doses (≤400 mg extract or ≤2 g KRG/day).
- Severe hypoglycemia when stacked on insulin / sulfonylureas / metformin.
- Hypertensive crisis / mania on MAOIs (phenelzine, tranylcypromine) — case reports.
- Bleeding / reduced anticoagulation with warfarin — case reports both directions (INR drop more common; Janetzky 1997 classic, Yuan 2004 RCT replication). Safe rule: do not combine without INR monitoring.
- Mania / hypomania in bipolar diathesis — case reports tie to dopaminergic / weak antidepressant signal.
- Estrogenic-cancer concern — theoretical SERM activity in vitro; caution in hormone-sensitive cancer.
- Anaphylaxis / allergic reactions — rare.
- Week 1–2: GI + headache. If persistent >7–10 days, halve or stop.
- Weeks 1–4: Sleep architecture on Colmi R06 ring. If REM/deep drops or SOL extends, dose earlier or stop.
- Week 4: 1-week washout placebo-expectancy check — re-rate fatigue/focus/libido.
- Baseline + 8 weeks: Resting HR/BP 3-morning average. Modafinil already adds 5–10 bpm; watch for additive rise.
- Not WADA-banned — permitted across tested categories. Use Informed Sport-certified product to avoid contamination concerns.
- Mild stim signal could amplify pre-spar adrenaline subjectively; avoid same-day use on heavy sparring days until tolerance is known.
References
Reay 2005 — G115 reduces blood glucose + improves cognitive performance under sustained mental activity (J Psychopharmacol; PMID 15982990)
Reay 2010 — G115 improves working memory + calmness in healthy young adults (Hum Psychopharmacol; PMID 20737519)
Hong 2002 — KRG for ED, double-blind crossover (J Urol; PMID 12394711)
Choi 1995 — KRG vs trazodone vs placebo for ED (Int J Impot Res; PMID 8750052)
Scaglione 1996 — G115 + flu vaccination, URTI prevention in elderly (PMID 8879982)
Vuksan 2008 — KRG improves glucose + insulin regulation in T2D (PMID 16860976)
Bach 2016 — Ginseng for fatigue + physical performance, meta-analysis (PMID 27822924)
Zeng 2024 — Ginseng on cognitive function, systematic review + meta (Phytother Res; PMID 39474788)
Li 2023 — Ginseng + herbal formulas for fatigue, meta-analysis (PMID 36730693)
Arring 2020 — Clinical + preclinical systematic review of P. ginseng for fatigue (PMID 32765262)
Jang 2008 — Red ginseng for ED, systematic review (PMID 18782224)
Dormal 2025 — Hydroponic Red P. ginseng 200 mg/day × 3 wk on stress, emotion, cognition (Nutrients; PMID 40289951)
Panossian 2020 — HRG80 vs traditional ginseng on stress-induced cognitive failure (PMID 32235339)
Teitelbaum 2022 — HRG80 open-label in CFS/fibromyalgia/post-viral fatigue (PMID 35056100)
Sung 2020 — KRG in middle-aged chronic fatigue (PMID 31987248)
Lee 2008 — KRG cognitive trial in MCI elderly (PMID 18580589)
Yuan 2004 — American ginseng reduces warfarin's effect (PMID 15238367)
Lee 2008 — Warfarin + P. ginseng in ischemic stroke patients (PMID 18637764)
Geng et al. 2010 — Ginseng for cognition, Cochrane review (PMID 21154383)
Kim et al. 2020 — G115 standardized ginseng extract safety + efficacy heritage review (PMID 32148399)
Latest research
- rctHydroponically grown Red Panax ginseng on stress, emotional processing, cognition — RCT (Dormal 2025)200 mg/day hydroponic red ginseng for 3 weeks (n=149) reduced PSS and negative affect, improved spatial planning RT and visual memory errors vs placebo in moderately stressed adults.
- metaEffects of Ginseng on Cognitive Function — Systematic Review and Meta-Analysis (Zeng 2024)15 RCTs / 671 patients — significant memory improvement (especially at high doses); null for global cognition, attention, executive function.
- metaGinseng and Ginseng Herbal Formulas for Symptomatic Management of Fatigue — Systematic Review and Meta-Analysis (Li 2023)Statistically significant fatigue reduction across cancer-related and idiopathic chronic fatigue cohorts; effect concentrated in cancer-fatigue subset.
How was your experience with this compound?
Anonymous · one vote per session · results below at 5+ votes.
See something off?
Most of this wiki is AI-generated. Suggest a correction, dosing update, or new evidence — we review every submission.